The global AI in ultrasound imaging market is projected to grow from USD 1.15 Bn (2025) to USD 2.57 Bn (2034) at a 8.6% CAGR, propelled by rising chronic/lifestyle diseases and rapid adoption of AI to elevate diagnostic accuracy and speed.
Download this Free Sample Now and Get the Complete Report and Insights of this Market Easily @ https://www.towardshealthcare.com/download-sample/5082
Market Size
➤Base year (2025): USD 1.15 Bn.
➤2030 (projection at stated CAGR 8.6%): USD 1.74 Bn (middle-of-decade adoption inflection from AI-assisted echo, OB/GYN, and PoCUS).
➤2034 (headline projection): USD 2.57 Bn.
➤Absolute dollar opportunity (2025–2034): USD 1.42 Bn incremental revenue.
➤Regional concentration (2023): North America >29.75% share, aided by strong infrastructure and reimbursement.
➤Solution mix signals (2024): Software tools led; Services fastest-growing as providers seek managed AI expertise and workflow support.
➤Technology mix signals (2024): 2D/3D/4D led; extracorporeal shockwave and Doppler see AI-driven upgrades; therapeutic HIFU/ESWL benefit from AI guidance.
➤End-user weight (2024): Hospitals dominated; research labs & diagnostic centers set to expand fastest.
Market Trends
➤3D/real-time 4D push: AI-assisted plane finding and reconstruction upgrade surgical precision and fetal assessments, lifting demand for premium imaging platforms.
➤Workflow automation: Auto-measurements, quality control, anomaly checklists, and study completeness reduce scan times and inter-operator variability.
➤PoCUS normalization: Guidance AI lowers skill barriers, enabling high-quality echo/abdominal scans in EDs, wards, and remote clinics.
➤Edge + cloud convergence: On-device inference for latency/privacy; cloud for fleet analytics, model updates, and reporting—software leads, services scale.
➤Regulatory momentum: FDA 2023 guidance-type approvals for ultrasound AI (adult echo image-capture guidance) unlock broader clinical use.
Consolidation & capability stacking: GE HealthCare–Intelligent Ultrasound (2024, USD 51M); Ultrasight–Mayo Clinic (2024); Philips AI cardio platform (2024); Samsung Z20 women’s health (2025); Wipro GE Versana Premier R3 (2025, “Make in India”).
➤Ethics & governance drag: Privacy, black-box explainability, and consent complexities pace adoption in some geographies.
➤AI-enhanced Doppler & therapy planning: Better flow quantification and shockwave targeting improve outcomes in cardio and renal stone workflows.
➤Vendor UI unification: Intuitive UI across product lines (e.g., Philips EPIQ/Affiniti) lowers training time and boosts multi-site standardization.
➤Rising diagnostic load: CVD, GI, and OB/GYN volumes strain radiology; AI triage + reporting sustains throughput and quality.
10 Deep Roles/Impacts of AI in Ultrasound Imaging
➤Plane detection & probe guidance: Real-time visual cues help non-experts acquire diagnostic-quality views in echo and fetal scans.
➤Auto-measurements & quantification: Consistent calipers (e.g., biometrics, ejection fraction proxies, intima-media thickness) cut reading time.
➤Anomaly highlighting & QA: Automated flags in standard planes (cardiac valves, fetal CNS/heart, liver/thyroid nodules) improve sensitivity.
➤Reconstruction & denoising: AI-based beamforming/speckle reduction refines 2D/3D/4D anatomy visibility at lower power.
➤Scan completeness checklists: Auto-populated checklists reduce omissions and speed sign-off, essential for OB anomaly scans.
➤Triage & worklist prioritisations: Suspicious studies bubble to the top; benign studies fast-tracked to discharge or routine follow-up.
➤Therapy guidance: ESWL targeting and HIFU planning optimize dose/trajectory for efficiency and tissue safety.
➤Doppler intelligence: Cleaner flow profiles, aliasing reduction, and velocity estimation assist vascular/cardiac decisions.
➤Training & competency leveling: AI overlays shrink learning curves; standardized outputs enable multi-center consistency.
➤Operational analytics: Fleet-level dashboards, protocol adherence, and variability tracking drive continuous improvement.
Regional Insights
North America (leader)
➣Adoption drivers: Advanced infrastructure, favorable reimbursement, and top med-tech vendors ensure rapid AI deployment.
➣United States: Strong R&D funding, regulatory clarity, and chronic disease burden expand AI-enhanced echo/vascular and OB volumes.
➣Canada: 3D/4D + AI upgrades efficiency; public investments and aging demographics push non-invasive diagnostics.
Europe
➣System readiness: Robust regulation, digitization, and hospital networks accelerate AI QA and workflow tools.
➣United Kingdom: NHS programs (e.g., AI in breast screening) alleviate backlogs; AI addresses radiologist shortages and reduces wait times.
➣Germany: ML innovation + industry-academia consortia drive early-diagnostic use cases and precision cardiology.
Asia-Pacific (fastest growth)
➣Cost-efficient manufacturing: APAC supplies affordable ultrasound devices; AI layers increase value without hardware overhaul.
➣China: Early detection push, aging population, and government innovation support spur hospital adoption of AI echo and liver US.
➣India: National digital health initiatives and Make in India manufacturing (Wipro GE Bangalore) improve access; portable AI-enabled PoCUS widens rural coverage.
Latin America
➣Value proposition: AI cuts per-study time and supports task-shifting in constrained radiology settings; private chains lead rollouts.
Middle East & Africa
➣Smart-hospital builds: New tertiary centers adopt AI US to standardize training and quality; portable AI aids underserved regions.
Market Dynamics
Drivers
➣Disease prevalence: CVD and GI disorders rising; faster, more accurate diagnostics needed at scale.
➣3D/4D clinical gains: Better fetal and surgical planning outcomes accelerate premium platform upgrades.
➣Workflow pressure: AI automation offsets staffing shortages and rising imaging volumes.
Restraints
➣Privacy & security: Patient data protection and breach risks slow some deployments.
➣Explainability & accountability: Black-box concerns complicate consent and liability frameworks.
➣Skill gaps: Sites need training to exploit AI beyond “demo features.”
Opportunities
➣PoCUS & primary care: Guidance AI unlocks community screening and remote triage.
➣Cloud services: Model lifecycle, multi-site analytics, and managed reporting fuel Services segment growth.
➣Therapeutic US synergy: ESWL/HIFU planning becomes a differentiated AI value pool.
Challenges
➣Validation at scale: Multi-vendor, multi-population robustness and drift management.
➣Integration: PACS/RIS/EMR harmonization and cybersecurity hardening.
➣Procurement models: Aligning AI value with capex/opex realities across regions.
Top 10 Companies
Philips
Product: EPIQ CVx/Affiniti CVx with next-gen AI for cardiovascular ultrasound.
Overview: Focus on end-to-end exam enhancement and intuitive UI across platforms.
Strengths: Deep cardiology portfolio, usability leadership, enterprise integration.
GE HealthCare
Product: Cardiac and PoCUS portfolio; Intelligent Ultrasound AI integrated post-acquisition (2024).
Overview: Global scale across premium carts to handheld; strong echo leadership.
Strengths: Broad channel reach, robust R&D, acquisitive capability stacking.
Wipro GE HealthCare (GE JV, India)
Product: Versana Premier R3 (2025) AI-enabled, manufactured in Bengaluru.
Overview: Localized design/production aligned to “Make in India.”
Strengths: Cost-effective innovation, regulatory familiarity, installed-base leverage.
Siemens Healthineers
Product: AI-augmented ultrasound workflows across imaging franchises.
Overview: Enterprise imaging and cardiology/vascular depth.
Strengths: Integration with broader diagnostic ecosystem; strong QA/measurement AI.
Samsung Healthcare / Boston Imaging
Product: Z20 (2025, women’s health); HERA W10 Elite (OB/GYN with AI, 2023).
Overview: Women’s health and OB leadership with premium image quality.
Strengths: Fast feature iteration, design ergonomics, OB toolset depth.
Butterfly Network
Product: Handheld PoCUS with AI guidance and cloud-based analytics.
Overview: Democratizes ultrasound at the point of care.
Strengths: Portability, price accessibility, edge-cloud architecture.
DiA Imaging Analysis
Product: AI modules for echo quantification and automated measurements.
Overview: Vendor-agnostic software that plugs into existing fleets.
Strengths: Interoperability, rapid deployment, measurable time savings.
Qure.ai
Product: AI for image triage/decision support; expanding into ultrasound use-cases.
Overview: Strong in clinical AI deployments in emerging and developed markets.
Strengths: Speed-to-value, scalable cloud services, public-health use-case experience.
Exo Imaging, Inc.
Product: Portable ultrasound platform with AI-driven workflow.
Overview: Bridging handheld performance with enterprise integration.
Strengths: Hardware-software co-design, PoCUS ergonomics, growing ecosystem.
Ultrasight
Product: AI guidance for cardiac ultrasound acquisition; Mayo Clinic collaboration (2024).
Overview: Lowers echo skill barrier for non-experts and remote settings.
Strengths: Probe guidance leadership, PoCUS enablement, clinical partnerships.
Latest Announcements
Wipro GE HealthCare (Mar 2025): Launched Versana Premier R3, an AI-enabled ultrasound to boost efficiency/accuracy; local manufacturing at Bengaluru PLI facility under “Make in India.”
Samsung (Jan 2025): Introduced Z20 in the U.S.—AI-powered women’s health ultrasound with elevated OB/GYN toolset.
GE HealthCare (Jul 2024): Acquired Intelligent Ultrasound for USD 51M to deepen AI workflow/ease-of-use capabilities.
Ultrasight (Jun 2024): Collaboration with Mayo Clinic to co-develop cardiac ultrasound AI for PoCUS acquisition/interpretation.
Philips (Jun 2024): Rolled out AI-enabled cardiovascular ultrasound platform integrated into EPIQ CVx/Affiniti CVx, cutting echo lab burden/tracing time.
Recent Developments
FDA (2023): Cleared the first ultrasound AI that guides users to capture diagnostically acceptable adult echocardiography images—pivotal for PoCUS quality.
Boston Imaging (Feb 2023): Launched HERA W10 Elite (OB/GYN) with robust AI applications for diagnostic improvement; U.S. sales/marketing hub.
UK health system: Scales AI programs to reduce screening wait times and address staffing shortages (e.g., breast screening initiatives).
Therapeutic ultrasound: AI used for ESWL targeting/monitoring and Doppler flow analytics—improving efficacy and outcomes.
Segments Covered
By Solution
Software Tools (Leader, 2024)
Core value props:
Diagnostic lift: AI auto-measurements (e.g., chamber dimensions, fetal biometrics) and anomaly flags raise sensitivity/specificity while cutting read times by minutes per study.
Consistency-at-scale: Model-driven QC reduces inter-operator variability; protocol adherence dashboards standardize multi-site output.
Compute flexibility: Hybrid deployment (edge inference + cloud training/updates) balances latency, privacy, and total cost of ownership (TCO).
Commercial & pricing patterns:
Per-console add-on or enterprise subscription (SaaS) with tiered features (basic QA → full reconstruction/triage).
Outcome-linked contracts: KPIs tied to time-to-report, repeat-scan reduction, and guideline-complete studies.
Integration & data fabric:
Interoperability: DICOM-SR, HL7/FHIR connectors; PACS/RIS/EMR single sign-on.
Analytics layer: Fleet QA, utilization heatmaps, operator coaching insights, and drift monitoring for model health.
Risk & mitigation:
Model drift: Scheduled revalidation; shadow-mode updates before go-live.
Explainability: Clinician-facing overlays (caliper placement, saliency cues) and audit trails to support trust and compliance.
Services (Fastest-growing)
What’s included:
Managed AI Ops: Model lifecycle (training, tuning, versioning), uptime SLAs, security hardening, and regulatory documentation.
Clinical enablement: Remote mentorship, protocol harmonization, competency tracking, and change-management playbooks.
Business outcomes: Study-throughput redesign, slot optimization, and performance reviews by service line.
Why buyers choose services:
Skill gaps: Bridges shortages in sonographers/echo readers; accelerates time-to-value.
Budget fit: Opex-friendly; predictable monthly cost bundles (software + support + QA audits).
KPIs often contracted:
≥10–25% reduction in average reporting time; ≥20–40% decrease in incomplete studies; measurable decline in callbacks.
Quality metrics: % guideline-complete OB anomaly scans; variance of measurements across operators/sites.
Devices
Design priorities:
AI-native consoles & handhelds: On-probe/on-cart inference for guidance and QC; offline mode for low-connectivity sites.
Human factors: Unified UI across product tiers (premium → mid → handheld) to shorten training and minimize cognitive load.
Enterprise readiness:
Cybersecurity: Zero-trust posture, secure boot, encrypted-at-rest images, and role-based access.
Connectivity: Seamless EMR/PACS push, worklist pull, and automated report templating.
Procurement angles:
Bundle deals: Hardware + AI software + services with enterprise discounts and multi-year refresh clauses.
Lifecycle planning: Clear pathways for GPU/ASIC upgrades and warranty extensions keyed to AI workloads.
By Ultrasound Technology
2D/3D/4D Diagnostic Imaging (Leader)
Clinical depth:
AI plane finding & reconstruction: Rapid standard planes for echo and fetal CNS/heart; reduces rescans and operator dependency.
Image quality: Speckle reduction and contrast lift at lower acoustic output; clearer borders for fine measurements.
Real-time 4D: Dynamic valve/fetal heart assessment; AI stabilizes volumes and auto-selects diagnostically useful frames.
Operational impact:
Throughput: Shorter exam times enable more daily slots without sacrificing quality.
Training: Embedded guidance and “exam completeness” checklists reduce ramp-up time for new staff.
Therapeutic (HIFU/ESWL)
AI planning & guidance:
Targeting: Automated lesion/stone localization, path planning, and dose/energy suggestions.
Monitoring: Real-time feedback loops on energy delivery and tissue response; records for post-therapy review.
Outcome advantages:
Efficacy: Optimized dosing reduces retreatment; improved tissue sparing supports better recovery.
Workflow: Pre-op simulation shortens in-room time; standardized protocols ease credentialing across centers.
Doppler Ultrasound
Signal intelligence:
Cleaner velocity profiles: Noise/aliasing mitigation for clearer assessment of regurgitant jets and stenoses.
Automation: Auto-ROI placement and flow quantification reduce manual calipers and errors.
Clinical pathways:
Vascular triage: Early detection prompts escalation for CTA/MRA where appropriate.
Cardiac follow-up: Consistent serial measurements improve longitudinal decision-making.
By End User
Hospitals (Leader, 2024)
Why hospitals lead:
Capital capacity: Premium carts + AI suites justified by multi-disciplinary use (cardiology, OB/GYN, ED).
Clinical trials & early access: Participation accelerates validation and clinician buy-in.
Economics: Reimbursement alignment + throughput gains → clear ROI narratives to CFOs.
Execution essentials:
Governance: AI oversight committees (radiology, cardiology, IT, compliance) define guardrails.
Scale-up playbook: Start with high-yield use-cases (echo, OB anomaly) → expand to liver/thyroid/breast.
Research Labs & Diagnostic Centers (Fastest-growing)
Growth mechanics:
Competitive differentiation: Turnaround time and standardized, AI-enriched reports as a marketable edge.
Large buyer base (U.S. context): 31,277 diagnostic/medical labs and 15,000+ imaging centers (2024) enable rapid AI diffusion.
Operating model:
High-utilization fleets: AI maximizes scanner uptime and uniformity across satellite sites.
Data-ready: Rich de-identified datasets support continuous model improvement and service innovation.
Clinics & Others
Access expansion:
PoCUS + guidance AI: Pushes diagnostic-quality imaging into ambulatory and rural settings with limited expert availability.
Subscription fit: Opex bundles (device + software + service) align with smaller-practice budgets.
Quality guardrails:
Standardized templates: Auto-reports with embedded QA checks; escalation rules for complex findings.
By Geography
North America
Adoption drivers: Mature reimbursement, strong vendor presence, and high chronic-disease load.
Operational focus: AI for lab de-bottlenecking (echo labs, ED triage), system-wide protocol standardization, and enterprise analytics.
Europe
System readiness: Advanced hospital IT and regulatory clarity favor scale deployments.
Priority use-cases: Backlog reduction in screening programs; explainability and audit trails emphasized by regulators.
Asia-Pacific
Fastest growth pattern: Cost-competitive manufacturing + rapid AI layering on existing fleets.
Country archetypes:
China: Early detection, aging demographics, and hospital digitization drive AI-echo and liver US uptake.
India: National digital health push; Make in India manufacturing and portable PoCUS extend reach to Tier-2/3 and rural clinics.
Latin America
Value thesis: AI boosts productivity per scanner and supports task-shifting where specialists are scarce; private chains lead pilots.
Middle East & Africa
Smart-hospital builds: New tertiary centers adopt AI US for training standardization and quality benchmarking; portability vital for outreach.
Cross-segment Implementation Blueprint (extras for depth)
Governance & Compliance: Define AI-use policy, consent language, audit trails, and model versioning; schedule periodic safety/efficacy reviews.
Change Management: Role-based training (sonographer vs. radiologist), competency tracking, and feedback loops for model tuning.
IT & Security: Network segmentation for devices, endpoint protection, encrypted DICOM transport, and SOC integration for alerts.
KPIs & ROI: Time-to-diagnosis, % guideline-complete studies, recall/repeat-scan rate, staff training hours, scanner utilization, and patient throughput.
Top 5 FAQs
-
What is the market size outlook?
From USD 1.15 Bn (2025) to USD 2.57 Bn (2034); stated 8.6% CAGR with ~USD 1.42 Bn incremental opportunity. -
Which region leads today and which grows fastest?
North America led (>29.75% in 2023); Asia-Pacific is the fastest-growing on manufacturing scale, policy support, and rising disease burden. -
Which solutions lead and which grow fastest?
Software tools led in 2024; Services will grow fastest due to managed AI ops and training/QA demand. -
Which ultrasound technologies matter most for AI?
2D/3D/4D dominate diagnostics; Doppler and therapeutic (HIFU/ESWL) benefit from AI targeting, flow analysis, and planning. -
What recent moves signal acceleration?
GE–Intelligent Ultrasound (2024, USD 51M), Ultrasight–Mayo Clinic (2024), Philips AI CV (2024), Samsung Z20 (2025), Wipro GE Versana R3 (2025), and FDA 2023 AI guidance for echo acquisition.
Access our exclusive, data-rich dashboard dedicated to the healthcare market – built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway.
Access the Dashboard: https://www.towardshealthcare.com/access-dashboard
Immediate Delivery Available | Checkout this Premium Research Report @ https://www.towardshealthcare.com/checkout/5082
Become a valued research partner with us – https://www.towardshealthcare.com/schedule-meeting
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
Powering Healthcare Leaders with Real-Time Insights: https://www.towardshealthcare.com/healthcare-intelligence-platform
Europe Region – +44 778 256 0738
North America Region – +1 8044 4193 44
APAC Region: +91 9356 9282 04
Web: https://www.towardshealthcare.com
Find us on social platforms: LinkedIn | Twitter | Instagram | Medium | Pinterest
About the Author
